在下肢外周动脉疾病中改善甲胺:PERMET随机临床试验
Mary M McDermott1, Kathryn J Domanchuk2, Lu Tian3
1Department of Medicine and Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
JAMA
|November 8, 2025
概括
在没有糖尿病的周围动脉疾病 (PAD) 患者中,甲素没有改善步行距离. 这项研究表明,在PAD患者中,甲胺不能有效提高步行表现.
科学领域:
- 心血管医学
- 药理学
- 临床试验
背景情况:
- 周围动脉疾病 (PAD) 显著影响行走能力.
- 在PAD患者中改善行走能力的有效治疗方法有限.
- 甲胺是一种糖尿病药物,具有对血管健康有益的潜在热效应.
研究的目的:
- 在没有糖尿病的PAD患者中,评估甲素改善6分钟步行距离的疗效.
- 在6个月的随访期间,将甲福明的效果与安慰剂进行比较.
主要方法:
- 在美国4个中心进行了一项随机双盲,安慰剂对照的临床试验.
- 202名患有PAD (50岁以上) 的参与者被随机分配给接受甲胺或安慰剂6个月.
- 主要结局是6分钟步行距离的变化;次要结局包括跑步机步行时间和生活质量得分.
主要成果:
- 与安慰剂相比,美特福林没有显著改善6分钟的步行距离 (调整后的差异为1.1米).
- 在使用甲胺的任何次要结果中没有发现显著改善.
- 常见的不良反应包括胃肠道乱和头痛;严重的不良反应在不同组之间是可比的.
结论:
- 在患有PAD和没有糖尿病的个体中,甲没有证明改善行走能力的有效性.
- 这些发现不支持在这种患者群体中使用甲素作为治疗剂来增强行走能力.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
554
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
554
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
311
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
311
Peripheral Artery Disease III: Interprofessional Care
215
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
215
Peripheral Artery Disease IV: Nursing Management
306
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
306
Peripheral Artery Disease I: Introduction
275
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
275
Peripheral Artery Disease V: Postoperative Nursing Management
343
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
343


